ATS GUIDELINES Bundle

Infant Wheezing

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link: http://eguideline.guidelinecentral.com/i/769848

Contents of this Issue

Navigation

Page 2 of 3

Diagnosis Î For infants who do not have eczema but have persistent wheezing despite treatment with bronchodilators, inhaled corticosteroids, or systemic corticosteroids, the ATS suggests that clinicians and caregivers do NOT use empiric food avoidance or dietary changes (conditional recommendation, very low quality of evidence). • The ATS recommends research studies that determine if food avoidance or dietary changes guided by food allerg y testing improves clinical outcomes in infants who do not have eczema but have persistent wheezing despite treatment with bronchodilators, inhaled corticosteroids, or systemic corticosteroids. Î For infants with persistent wheezing despite treatment with bronchodilators, inhaled corticosteroids, or systemic corticosteroids, the ATS suggests 24-hour esophageal pH monitoring (conditional recommendation, very low quality of evidence). Î For infants with persistent wheezing despite treatment with bronchodilators, inhaled corticosteroids, or systemic corticosteroids, the ATS suggests 24-hour esophageal pH monitoring rather than upper gastrointestinal radiography (conditional recommendation, very low quality of evidence). Î For infants with persistent wheezing despite treatment with bronchodilators, inhaled corticosteroids, or systemic corticosteroids, the ATS suggests 24-hour esophageal pH monitoring rather than gastrointestinal scintigraphy (conditional recommendation, very low quality of evidence). Î For infants with persistent wheezing despite treatment with bronchodilators, inhaled corticosteroids, or systemic corticosteroids, the ATS suggests performing videofluoroscopic swallowing studies (conditional recommendation, very low quality of evidence).

Articles in this issue

view archives of ATS GUIDELINES Bundle - Infant Wheezing